Stocks that pay dividends tend to outperform ones that don't. Consensus price targets for Novo Nordisk suggest the stock can ...

A survey reveals that while awareness of weight loss drugs is rising in India, a majority of citizens prefer non-medical methods due to concerns over side effects and safety. Experts advocate for a ...

Managed by Terry Smith -- often dubbed the UK’s Warren Buffett -- this £20bn fund remains a staple in many Stocks and Shares ISAs. The post Should I buy Fundsmith Equity for my Stocks and Shares ISA?

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

The lack of details about which countries are involved and which companies will be impacted as a result of the new trade deal ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...

WeightWatchers will announce on Tuesday Dr. Kim Boyd as its chief medical officer, and plans for a new program to help women manage the transition into menopause and beyond, part of its growth ...

Health news highlights the booming demand for obesity drugs in India with companies like Eli Lilly and Novo Nordisk vying for ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Italian authorities on Monday appointed a special commissioner to help Danish drugmaker Novo Nordisk speedily deliver its ...